Literature DB >> 730828

Serological typing of Ureaplasma urealyticum isolates from urethritis patients by an agar growth inhibition method.

M C Shepard, C D Lunceford.   

Abstract

An agar growth inhibition method for serotyping Ureaplasma urealyticum is described, and the results of applying this method to serotyping 338 strains of the organism are presented. The serotyped strains consisted of cloned isolates from male patients with primary and recurrent nongonococcal urethritis (NGU), isolates from symptomatic patients with other genitourinary tract infections and disorders, and isolates from asymptomatic carriers of U. urealyticum in the genitourinary tract (controls). Among 122 male patients with NGU, serotype 4 was associated most frequently (52%) with this disease at Camp Lejeune, N.C. Seventeen percent of the isolates were type 2. The remaining isolates consisted of types 1, 3, 6, and 8 and accounted for 6 to 9% each of the serotypes isolated from the NGU group. Types 5 and 7 were not isolated. Among 91 symptomatic patients with other genitourinary tract infections and disorders, U. urealyticum type 4 also was associated most frequently (37%) with these disorders. The remaining isolates, represented by types 1, 2, 3, 6, 7, and 8, accounted for 9 to 15% each of the types isolated from this group. Type 5 was not isolated. Among 125 symptomfree carriers of U. urealyticum in the genitourinary tract, type 8 was recovered most frequently (30%), whereas type 4 was isolated next most frequently (24%). The remaining isolates consisted of types 1, 2, 3, 5, and 6 and accounted for 2 to 15% each in this asymptomatic control group. Type 7 was not isolated. Of the present eight serotypes of U. urealyticum studied in this investigation, type 4 was associated most frequently with disease (NGU) and certain other disorders of the genitourinary tract at Camp Lejeune. A previously unknown association of U. urealyticum with frequently abacteriuric, unexplained pyuria (with or without urethral pruritus and dysuria) is reported, suggesting the existence of asymptomatic Ureaplasma urethritis.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 730828      PMCID: PMC275298          DOI: 10.1128/jcm.8.5.566-574.1978

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  20 in total

1.  Modifications of the growth inhibition test and its application to human T-mycoplasmas.

Authors:  F T Black
Journal:  Appl Microbiol       Date:  1973-04

2.  Characterization and classification of bovine mycoplasma.

Authors:  J M al-Aubaidi; J Fabricant
Journal:  Cornell Vet       Date:  1971-07

3.  Identification of "T" mycoplasmas in primary agar cultures by means of a direct test for urease.

Authors:  M C Shepard; D R Howard
Journal:  Ann N Y Acad Sci       Date:  1970-10-30       Impact factor: 5.691

4.  Serologic typing of human genital T-mycoplasmas by a complement-dependent mycoplasmacidal test.

Authors:  J S Lin; M I Kendrick; E H Kass
Journal:  J Infect Dis       Date:  1972-12       Impact factor: 5.226

5.  Differential methods for identification of T-mycoplasmas based on demonstration of urease.

Authors:  M C Shepard
Journal:  J Infect Dis       Date:  1973-03       Impact factor: 5.226

6.  Immune inactivation of T-strain mycoplasmas.

Authors:  J S Lin; E H Kass
Journal:  J Infect Dis       Date:  1970 Jul-Aug       Impact factor: 5.226

7.  Relationships between mycoplasma and the etiology of nongonococcal urethritis and Reiter's syndrome.

Authors:  D K Ford
Journal:  Ann N Y Acad Sci       Date:  1967-07-28       Impact factor: 5.691

8.  Differential agar medium (A7) for identification of Ureaplasma urealyticum (human T mycoplasmas) in primary cultures of clinical material.

Authors:  M C Shepard; C D Lunceford
Journal:  J Clin Microbiol       Date:  1976-06       Impact factor: 5.948

9.  Strain of mycoplasma associated with human reproductive failure.

Authors:  R B Kundsin; S G Driscoll; P L Ming
Journal:  Science       Date:  1967-09-29       Impact factor: 47.728

10.  Urease color test medium U-9 for the detection and identification of "T" mycoplasms in clinical material.

Authors:  M C Shepard; C D Lunceford
Journal:  Appl Microbiol       Date:  1970-10
View more
  46 in total

1.  Characterization of phospholipase A1, A2, C activity in Ureaplasma urealyticum membranes.

Authors:  N S DeSilva; P A Quinn
Journal:  Mol Cell Biochem       Date:  1999-11       Impact factor: 3.396

2.  Hemadsorption by colonies of Ureaplasma urealyticum.

Authors:  J A Robertson; R Sherburne
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

Review 3.  The Human Ureaplasma Species as Causative Agents of Chorioamnionitis.

Authors:  Emma L Sweeney; Samantha J Dando; Suhas G Kallapur; Christine L Knox
Journal:  Clin Microbiol Rev       Date:  2016-12-14       Impact factor: 26.132

4.  Survival of feline mycoplasmas in urine.

Authors:  M B Brown; M Stoll; J Maxwell; D F Senior
Journal:  J Clin Microbiol       Date:  1991-05       Impact factor: 5.948

5.  Polymerase chain reaction using 16S rRNA gene sequences distinguishes the two biovars of Ureaplasma urealyticum.

Authors:  J A Robertson; A Vekris; C Bebear; G W Stemke
Journal:  J Clin Microbiol       Date:  1993-04       Impact factor: 5.948

6.  Comparison of the antibacterial activity of norfloxacin (MK 0366, AM 715), a new organic acid, with that of other orally absorbed chemotherapeutic agents.

Authors:  H H Gadebusch; D L Shungu; E Weinberg; S K Chung
Journal:  Infection       Date:  1982-01       Impact factor: 3.553

7.  Chlamydial endometritis.

Authors:  J Paavonen; R Aine; K Teisala; P K Heinonen; R Punnonen; M Lehtinen; A Miettinen; P Grönroos
Journal:  J Clin Pathol       Date:  1985-07       Impact factor: 3.411

8.  Modified indirect immunofluorescence test for serotyping large numbers of Ureaplasma urealyticum clinical isolates.

Authors:  A Naessens; S Lauwers
Journal:  J Clin Microbiol       Date:  1987-01       Impact factor: 5.948

9.  In vitro susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum to sparfloxacin and PD 127391.

Authors:  K B Waites; L B Duffy; T Schmid; D Crabb; M S Pate; G H Cassell
Journal:  Antimicrob Agents Chemother       Date:  1991-06       Impact factor: 5.191

10.  Localization of endogenous activity of phospholipases A and C in Ureaplasma urealyticum.

Authors:  N S De Silva; P A Quinn
Journal:  J Clin Microbiol       Date:  1991-07       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.